The Pediatric Infectious Disease Journal · 2010 · 33 citations · 14 references
MedicineHematologyPediatricsInfant HealthPediatric HematologyPediatric ImmunologyAnemiaAntiretroviral TherapyMother-to-child Transmission PreventionNeonatal Drug TherapyNeonatal HematologyNeonatal PharmacotherapyEarly Antiretroviral TherapyHiv Infection In InfantsHuman Immunodeficiency Virus TransmissionMother-to-child Hiv TransmissionNeonatal Antiretroviral ProphylaxisNeonatal Antiviral TherapyObservational Study AnalysisPediatric Antiretroviral Therapy
Recent updates of the guidelines on the prevention of human immunodeficiency virus mother-to-child transmission have shortened the neonatal zidovudine prophylactic regimens from 6 to 4 weeks. We present a prospective observational study in a large cohort of mother-infant pairs and report that the 4-week regimen allows an earlier recovery of the anemia in these otherwise healthy infants.
14
Adelisa L. Panlilio, Denise M. Cardo, Lisa A. Grohskopf et al. · PsycEXTRA Dataset · 2005 · 1.3K citations
Public Health, Infectious Disease Control, Hiv Prevention +15
Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants
Jérôme Le Chenadec, Marie-Jeanne Mayaux, Chantal Guihenneuc‐Jouyaux et al. · AIDS · 2003 · 152 citations
Medicine, Hematology, Pediatrics +17